Takenobu Katagiri

10PUBLICATIONS
11CO-AUTHORS
Solid tumoursCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsSocial and affective neuroscienceBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Apr 22, 2026
In vivo mouse model of calcific myonecrosis induced by injury.

|Aug 04, 2023
Wnt7b expressed by hypertrophic chondrocytes is a stimulatory factor for endochondral ossification that is regulated by Smad4 activity.

Sho Tsukamoto, Mai Kuratani, Shinya Tanaka

|May 25, 2023
A blocking monoclonal antibody reveals dimerization of intracellular domains of ALK2 associated with genetic disorders.

Takenobu Katagiri, Sho Tsukamoto, Mai Kuratani

|Jul 27, 2022
Critical Roles of NF-κB Signaling Molecules in Bone Metabolism Revealed by Genetic Mutations in Osteopetrosis.

Eijiro Jimi, Takenobu Katagiri

|Jul 02, 2021
Accumulated Knowledge of Activin Receptor-Like Kinase 2 (ALK2)/Activin A Receptor, Type 1 (ACVR1) as a Target for Human Disorders.

Takenobu Katagiri, Sho Tsukamoto, Mai Kuratani

|Dec 03, 2020
Screening for Small Molecule Inhibitors of BMP-Induced Osteoblastic Differentiation from Indonesian Marine Invertebrates.

Hiroyuki Yamazaki, Satoshi Ohte, Henki Rotinsulu

Pageof 2

Frequent Collaborators

4 joint publications

Mai Kuratani

3 joint publications

Sho Tsukamoto

2 joint publications

Yutaka Nakachi

2 joint publications

Kensuke Nakamura